Mary Fisher

Mary Fisher (board member) discloses dealings in 3 companies, chiefly Dermata Therapeutics, Inc., Sientra, Inc. and Tempest Therapeutics, Inc. We count 8 filings; the first trade dates from 31 December 2015 and the latest from 21 January 2025.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 23 January 2025, reports a share grant in Dermata Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.